Fractyl Health, Inc.
(NASDAQ: GUTS)
Fractyl Health, Inc. is a metabolic therapeutics company. It develops medical device solutions for the treatment of metabolic diseases, which includes type 2 diabetes and obesity. The company was founded by Harith Rajagopalan and Jay D. Caplan on August 30, 2010 and is headquartered in Burlington, MA.
1.980
+0.060
(+3.13%)
Range
1.860 - 2.050
(10.22%)
Open
1.910
Previous Close
1.920
Bid Price
-
Bid Volume
-
Ask Price
-
Ask Volume
-
Volume
3,770,446
Value
-
Remark
Delayed prices. Updated at 05 Dec 2025 05:00.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
